Vulvar cancer is a type of cancer that occurs on the external female genitalia, specifically affecting the vulva. This condition is relatively rare compared to other female reproductive system cancers and often arises from precancerous conditions like vulvar intraepithelial neoplasia (VIN). Symptoms may initially be subtle, leading to delayed diagnosis, but early detection is crucial for successful treatment outcomes. Treatment options generally include surgery, radiation therapy, or chemotherapy, depending on the stage and extent of the disease.

Several factors can increase the risk of developing vulvar cancer, including age, as most cases occur in women over 65. Other significant risk factors include human papillomavirus (HPV) infection, a history of vulvar intraepithelial neoplasia, and certain chronic skin conditions. Additionally, smoking and immunosuppression can also contribute to elevated risk levels, particularly in individuals with compromised immune systems.

Common symptoms of vulvar cancer may include persistent itching, burning sensations, or pain in the vulvar area. Other signs can manifest as changes in the skin of the vulva, such as the appearance of lumps, warts, or sores that do not heal. Unexplained bleeding or discharge from the vagina may also occur. It is vital for women to seek medical attention if they experience any of these symptoms, as early intervention may improve prognosis.

Vulvar cancer is often linked to several risk factors, including human papillomavirus (HPV) infection, particularly HPV types 16 and 18, which are known to contribute to the development of pre-cancerous lesions and invasive cancers. Other contributing factors include a history of vulvar intraepithelial neoplasia (VIN), smoking, immunosuppression, and certain skin conditions like lichen sclerosus. Women over the age of 60 are more frequently diagnosed, highlighting age as a significant risk factor.

Diagnosis of vulvar cancer typically involves a thorough physical examination and the evaluation of symptoms followed by a biopsy of any suspicious lesions. Imaging tests, such as ultrasound, MRI, or CT scans, may be utilized to determine the extent of the cancer. Once diagnosed, staging is critical to guide treatment, which assesses if the cancer has spread to nearby lymph nodes or other organs.

Treatment for vulvar cancer typically involves a multidisciplinary approach, starting with surgical options such as vulvectomy, which is the removal of part or all of the vulva. Depending on the stage and extent of cancer, additional treatments like radiation therapy and chemotherapy may be recommended to combat any residual cancer cells or metastases. Targeted therapies may also be explored in advanced cases, particularly in the context of personalized medicine.

Preventive measures for vulvar cancer primarily focus on addressing risk factors. Vaccination against HPV can significantly reduce the risk of developing HPV-related cancers, including vulvar cancer. Regular gynecological check-ups and self-examinations can help detect any abnormalities early on. Additionally, avoiding smoking and managing chronic skin conditions can also contribute to lower risk levels.